GLP-1 weight loss drugs cost CT’s Medicaid program $85 million in FY 2024, 35% of annual Medicaid pharmaceutical budget ...

Semaglutide is already available in Ireland through diabetes medication Ozempic. However, its producer Novo Nordisk uses the ...

Amy Schumer endorses the new weight loss drug Mounjaro, praising its effectiveness after an adverse experience with Wegovy.

Amy Schumer admitted she was using a new weight loss medication and praised the many benefits of Mounjaro after difficult time using Ozempic years ago.

The European Medicines Agency (EMA) has advised that the drug can be used together with diet and physical activity to help ...

Amy Schumer has revealed that she's back on a new weight loss drug after her "horrible experience" with Wegovy.

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo ...

Counterfeit medications are a growing menace, with alarming revelations surfacing about dangerous fake weight-loss drugs circulating among consumers. U.S. and UK health authorities have issued urgent ...

Ozempic and alcohol-use disorder were central to a recent study that showed the weight-loss drug helped decrease bingeing. Is ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Hims & Hers Health, Inc. stock faces volatility after an FDA halt on its GLP-1 drug. Click here to find out why HIMS stock is ...